One study demonstrated that MUC13 is required in colonic cells for activation of NF-κB and found that silencing MUC13 significantly reduced NF-κB activation and subsequently sensitized colorectal cancer cells to death [29]. Here, NFKB1 is linked to colorectal cancer.